– L’ATH-063 est une nouvelle petite molécule thérapeutique orale révolutionnaire qui cible l’inflammation et induit une cicatrisation directe de la muqueuse chez les patients atteints de colite ulcéreuse et de la maladie de Crohn LOS ANGELES, 30 mars 2023 /PRNewswire/ — Athos…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.